Avalon GloboCare Corp. (NASDAQ:ALBT) Short Interest Update

Avalon GloboCare Corp. (NASDAQ:ALBT) saw a significant growth in short interest in June. As of June 15th, there was short interest totalling 202,900 shares, a growth of 120.1% from the May 31st total of 92,200 shares. Based on an average trading volume of 2,760,000 shares, the short-interest ratio is presently 0.1 days. Approximately 4.5% of the company’s stock are short sold.

Avalon GloboCare Stock Down 4.0 %

Shares of ALBT opened at $0.47 on Friday. Avalon GloboCare has a 12 month low of $0.24 and a 12 month high of $1.70. The company’s fifty day moving average is $0.38 and its 200-day moving average is $0.39. The firm has a market cap of $5.22 million, a price-to-earnings ratio of -0.33 and a beta of 0.30.

Avalon GloboCare (NASDAQ:ALBT) last issued its quarterly earnings data on Thursday, May 30th. The company reported ($0.12) earnings per share for the quarter. The firm had revenue of $0.32 million for the quarter.

About Avalon GloboCare

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China. The company develops and delivers transformative cellular therapeutics, precision diagnostics, and clinical laboratory services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells.